RXinsider Highlights Endo Experts on the Key Benefits of Ready-to-Use Products in Hospitals
Health & Patients
At Endo, our unwavering commitment to helping everyone we serve live their best life drives our work and our success. We have built a strong reputation for delivering high-quality products and providing exceptional customer service.
RXinsider recently highlighted this dedication and insights from our Injectable Solutions team in advancing ready-to-use medications, or RTUs.
We are addressing critical healthcare challenges such as hospital workflow efficiency and patient care optimization to help reduce complexity within hospital settings—when every second matters.
Some key benefits of adopting RTU products in healthcare systems include:
1. Improved Operational Efficiency
RTU products may contribute to greater workflow efficiency and save time.1 Their accessibility and convenience allow healthcare professionals to devote more time to other critical tasks, saving time and effort.2 This is particularly important for those with busy schedules and patient rosters.
Additionally, RTU products support hospital efficiency and potential cost savings.2
2. Reduced Risk of Medication Errors
RTU products are premixed and ready to administer, minimizing the number of steps required for manual preparation, such as measuring or mixing. This helps reduce the risk of preparation and medication error.3
3. Minimized Waste
RTU products support efforts to reduce waste,4 aligning with global efforts to create greener healthcare systems.
Many RTU products offer an extended shelf life. This enables hospitals to optimize inventory management by reducing the need for frequent restocking.1
Endo’s RTU product line, TruDelivery®, is designed to help meet the real challenges that our customers face every day. Through innovation and dedication to serving patients within hospitals and healthcare systems, the Endo Injectable Solutions team is driving meaningful change for both providers and patients worldwide.
Find out more about our RTU products at TruDelivery.com.
References:
1. Fanikos J, Burger M, Canada T, et al. An assessment of currently available i.v. push medication delivery systems. Am J Health-Syst Pharm. 2017;74:e230-235.
2. van der Linden P, Douchamps J, Schmitt C, Forget D. Ready-to-use injection preparations versus conventional reconstituted admixtures: economic evaluation in a real-life setting. Pharmacoeconomics. 2002;20(8):529-536.
3. American Society of Health System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Health-Syst Pharm. 2018;75(19):1493-1517.
4. American Society of Health-System Pharmacists. ASHP guidelines on medication cost management strategies for hospitals and health systems. Am J Health-Syst Pharm. 2008;65:1368-84.
